FindTrial
Sign In

Analysis of gene expression profiles in chemotherapy induced peripheral neuropathy

Analysis of gene expression profiles in chemotherapy induced peripheral neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0005059
Enrollment
30
Registered
2020-05-27
Start date
2020-07-06
Completion date
Unknown
Last updated
2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Chonnam National University Hospital Hwasun Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Male or female patients receiving chemotherapy, including oxaliplatin, to treat cancer Eastern Cooperative Oncology Group performance status (ECOG-PS) grade 2 or less Patients who voluntarily consented to this study

Exclusion criteria

Exclusion criteria: Pregnant or lactating women Patients with experience in chemotherapy Patients diagnosed with carpal tunnel syndrome, spinal stenosis, diabetic neuropathy, or other neuropathy prior to chemotherapy Patients diagnosed with brain metastasis Patients on medication for severe depression or mood disorders Patients judged unsuitable by investigator judgment

Design outcomes

Primary

MeasureTime frame
Gene expression—

Secondary

MeasureTime frame
Functional Assessment of Cancer Therapy / Gynecologic Oncology Group-Neurotoxicity;National Cancer Institute-Common Toxicity Criteria (NCI-CTC) scale—

Countries

Korea, Republic of

Contacts

Public ContactWoong Mo Kim

Chonnam National University Hospital Hwasun Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026